Skye Bioscience, Inc.
SKYE
$3.29
-$0.26-7.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.96% | -13.44% | 1.49% | -9.05% | -11.20% |
| Total Receivables | -7.53% | 10.61% | 3.94% | -97.69% | -0.58% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 119.64% | 184.85% | -69.61% | -39.36% | 71.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -77.60% | 46.33% | -81.26% | 4.27% | 13.39% |
| Total Current Assets | -19.75% | -11.01% | -11.25% | -8.27% | -8.00% |
|
|
|||||
| Total Current Assets | -19.75% | -11.01% | -11.25% | -8.27% | -8.00% |
| Net Property, Plant & Equipment | -10.93% | -9.09% | 10.67% | 583.72% | -3.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 104.94% | 216.87% | 0.00% |
| Total Assets | -19.50% | -10.95% | -10.76% | -6.56% | -7.99% |
|
|
|||||
| Total Accounts Payable | 88.03% | 201.04% | -27.01% | -27.74% | -1.42% |
| Total Accrued Expenses | 105.33% | -14.96% | -40.43% | 31.90% | -41.45% |
| Short-term Debt | -- | -- | -- | -- | 5.43% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.39% | 3.40% | 120.02% | 4.67% | 4.90% |
| Total Finance Division Other Current Liabilities | -5.59% | 5.18% | 1.48% | -70.39% | -1.99% |
| Total Other Current Liabilities | -5.59% | 5.18% | 1.48% | -70.39% | -1.99% |
| Total Current Liabilities | 56.25% | 22.60% | -22.85% | -60.73% | -9.36% |
|
|
|||||
| Total Current Liabilities | 56.25% | 22.60% | -22.85% | -60.73% | -9.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 5.43% |
| Capital Leases | -22.82% | -18.19% | 152.73% | -16.78% | -13.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 53.06% | 20.18% | -19.54% | -60.34% | -9.40% |
|
|
|||||
| Common Stock & APIC | 1.02% | 1.11% | 1.06% | 3.63% | 0.97% |
| Retained Earnings | -12.41% | -8.48% | -8.04% | -3.32% | -7.22% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -26.28% | -13.06% | -10.09% | 4.11% | -7.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.28% | -13.06% | -10.09% | 4.11% | -7.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.28% | -13.06% | -10.09% | 4.11% | -7.70% |
|
|
|||||